Multiple Choice
Up to 21% of Asians are ultra-rapid 2D6 metabolizers, leading to:
A) A need to monitor drugs metabolized by 2D6 for toxicity
B) Increased dosages needed of drugs metabolized by 2D6, such as the selective serotonin reuptake inhibitors
C) Decreased conversion of codeine to morphine by CYP 2D6
D) The need for lowered dosages of drugs, such as beta blockers
Correct Answer:

Verified
Correct Answer:
Verified
Q2: Ultra-rapid metabolizers of drugs may have:<br>A) To
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Carbamazepine has a Black Box Warning recommending
Q5: Warfarin resistance may be seen in patients
Q6: A provider may consider testing for CYP2D6
Q7: Patients who have a poor metabolism phenotype
Q8: Rifampin is a nonspecific CYP450 inducer that
Q10: Inhibition of P-glycoprotein by a drug such
Q11: Pharmacogenetic testing is required by the U.S.
Q12: Genetic testing for VCORC1 mutation to assess